Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-01-17 Sale | 2025-01-17 9:17 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 5,584 | $0.5808 | $3,243 | 7,510 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 9:17 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 5,584 | $0.5808 | $3,243 | 7,510 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 9:16 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 5,584 | $0.5808 | $3,243 | 7,510 (Direct) | View |
| 2025-01-17 Sale | 2025-01-17 9:15 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 30,601 | $0.5808 | $17,773 | 44,327 (Direct) | View |
| 2025-01-13 Sale | 2025-01-15 4:19 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 59,569 | $0.5815 | $34,639 | 41,582 (Direct) | View |
| 2025-01-15 Sale | 2025-01-15 4:18 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 12,991 | $0.5748 | $7,467 | 18,421 (Direct) | View |
| 2025-01-13 Sale | 2025-01-15 4:17 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 22,195 | $0.58211 | $12,920 | 13,756 (Direct) | View |
| 2025-01-13 Sale | 2025-01-15 4:16 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 19,542 | $0.58133 | $11,360 | 13,756 (Direct) | View |
| 2025-01-13 Sale | 2025-01-15 4:15 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 19,542 | $0.58133 | $11,360 | 13,756 (Direct) | View |
| 2024-06-18 Sale | 2024-06-18 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 24,531 | $0.93 | $22,814 | 38,293 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 39,384 | $0.70064 | $27,594 | 44,848 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:31 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 20,563 | $0.68601 | $14,106 | 19,257 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:30 pm | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 22,795 | $0.69703 | $15,889 | 19,015 (Direct) | View |
| 2024-01-16 Sale | 2024-01-17 5:30 pm | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 23,589 | $0.69622 | $16,423 | 20,201 (Direct) | View |
| 2024-01-11 Sale | 2024-01-12 5:00 pm | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 11,808 | $0.84819 | $10,015 | 11,841 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-20 Option Award | 2025-02-20 5:35 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 2,686,728 | $0 | 2,686,728 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-20 5:34 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 2,686,728 | $0 | 2,686,728 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-20 5:33 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 2,686,728 | $0 | 2,686,728 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-20 5:32 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 2,686,728 | $0 | 2,686,728 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-20 5:31 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 2,686,728 | $0 | 2,686,728 (Direct) | View |
| 2025-02-20 Option Award | 2025-02-20 5:30 pm | N/A 2035-02-20 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 8,572,080 | $0 | 8,572,080 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:10 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 1,144,686 | $0 | 1,144,686 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:04 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | MOTT DAVID M Director | 1,583,214 | $0 | 1,583,214 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:03 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 1,121,604 | $0 | 1,121,604 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:03 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Hege Kristen Director | 660,000 | $0 | 660,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:02 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Hegde Priti Director | 1,144,686 | $0 | 1,144,686 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:02 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Furey John Director | 660,000 | $0 | 660,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:01 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Alleva Lawrence M Director | 1,213,926 | $0 | 1,213,926 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-01 5:00 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Allen Andrew R Director | 660,000 | $0 | 660,000 (Direct) | View |
Ownership | 2024-03-26 12:00 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | EcoR1 Capital LLC 10% Owner | 0 | $0 | 164,424,420 (Indirect) | View |
| 2024-03-18 Option Award | 2024-03-18 5:00 pm | N/A 2034-03-18 | Adaptimmune Therapeutics PLC | ADAP | Piccina Cintia Chief Commercial Officer | 6,219,696 | $0 | 6,219,696 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:06 pm | 2025-01-15 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Behbahani Ali Director | 40,950 | $0 | 40,950 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:03 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Bertrand William C JR Chief Operating Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:03 pm | 2025-01-15 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Hege Kristen Director | 81,906 | $0 | 81,906 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:02 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Lunger John Chief Patient Supply Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:02 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Brewer Joanna Elizabeth Chief Scientific Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Norry Elliot Chief Medical Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2024-01-15 Option Award | 2024-01-17 5:00 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Rawcliffe Adrian Chief Executive Officer | 9,329,568 | $0 | 9,329,568 (Direct) | View |